M Weller1. Show Affiliations » 1. Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: michael.weller@usz.ch.
Abstract
Mesh: See more » Antineoplastic Agents, Alkylating/therapeutic useBrain Neoplasms/mortalityBrain Neoplasms/therapyCombined Modality Therapy/methodsElectric Stimulation Therapy/methodsGlioblastoma/mortalityGlioblastoma/therapyHumansNeoplasm Recurrence, Local/mortalityNeoplasm Recurrence, Local/therapyProgression-Free SurvivalRandomized Controlled Trials as TopicTemozolomide/therapeutic use
Substances: See more » Antineoplastic Agents, AlkylatingTemozolomide
Year: 2018 PMID: 29905756 DOI: 10.1093/annonc/mdy220
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976